首页> 外文OA文献 >Identification of the first blaCMY-2 gene in Salmonella enterica serovar Typhimurium isolates obtained from cases of paediatric diarrhoea illness detected in South America
【2h】

Identification of the first blaCMY-2 gene in Salmonella enterica serovar Typhimurium isolates obtained from cases of paediatric diarrhoea illness detected in South America

机译:从南美南美地区小儿腹泻病病例中分离出肠炎沙门氏菌鼠伤寒沙门氏菌中的第一个blaCMY-2基因

摘要

The objectives of this study were to investigate clinical isolates of Salmonella enterica serovar Typhimurium resistant to β-lactam antibiotics, to characterise their mechanisms of antibiotic resistance and to evaluate the possible biological cost of expressing resistance genes. Two oxyimino-cephalosporin-resistant Salmonella isolates obtained from children with diarrhoea were characterised. The occurrence of plasmid-encoded bla CMY-2 genes was confirmed by molecular methods and conjugation assays; transcription levels were determined by quantitative real-time PCR (qRT-PCR). The genomic context of the β-lactamases, replicon type and addiction systems were analysed by PCR. Genomic relatedness of both isolates was studied by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) assays. Growth curves, motility and invasiveness assays in Caco-2 cells were performed to analyse the bacterial fitness of both isolates. Both isolates carried a blaCMY-2-like allele in an IncI plasmid and belonged to the same MLST sequence type (ST19); nevertheless, they showed extensive differences in their PFGE profiles and virulotypes. Isolate STM709 appeared to lack the Salmonella virulence plasmid and displayed less motility and invasiveness in cultured cells than isolate STM910. qRT-PCR showed that isolate STM709 had higher blaCMY-2 mRNA levels compared with STM910. Altogether, the results suggest that a plasmid carrying blaCMY-2 could be disseminating among different clones of S. Typhimurium. Different levels of blaCMY-2 mRNA could have an effect on the fitness of this micro-organism, resulting in lower invasiveness and motility. © 2013 International Society for Chemotherapy of Infection and Cancer.
机译:这项研究的目的是调查临床上对β-内酰胺类抗生素有抗性的鼠伤寒沙门氏菌的临床分离株,以表征其抗药性机制,并评估表达抗性基因的可能生物学成本。表征了从腹泻儿童获得的两种对氧亚氨基头孢菌素耐药的沙门氏菌。质粒编码的bla CMY-2基因的存在已通过分子方法和缀合试验得以证实。通过定量实时PCR(qRT-PCR)确定转录水平。通过PCR分析β-内酰胺酶的基因组背景,复制子类型和成瘾系统。通过脉冲场凝胶电泳(PFGE)和多基因座序列分型(MLST)分析研究了两种分离物的基因组相关性。在Caco-2细胞中进行生长曲线,运动性和侵袭性分析,以分析两种分离物的细菌适应性。两种分离物均在IncI质粒中带有blaCMY-2-like等位基因,并且属于相同的MLST序列类型(ST19)。但是,他们在PFGE谱和病毒型上显示出很大的差异。分离株STM709似乎缺乏沙门氏菌毒力质粒,并且与分离株STM910相比,在培养细胞中显示出较低的运动性和侵袭性。 qRT-PCR显示,与STM910相比,分离株STM709具有更高的blaCMY-2 mRNA水平。总之,结果表明携带blaCMY-2的质粒可以在鼠伤寒沙门氏菌的不同克隆中传播。不同水平的blaCMY-2 mRNA可能对该微生物的适应性有影响,从而导致较低的侵袭性和运动性。 ©2013国际感染与癌症化学治疗学会。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号